Islet Dysregulation in Infants with Congenital Hyperinsulinism
先天性高胰岛素血症婴儿的胰岛失调
基本信息
- 批准号:8764054
- 负责人:
- 金额:$ 71.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-05-01 至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:10q2111p11q8 year oldAKT2 geneAccountingAcyl CoA DehydrogenasesAddressAdultAdverse effectsAffectAffinityAfrica South of the SaharaAfrican AmericanAgeAllelesAlpha CellAmericanAmino AcidsAneuploidyAppearanceAreaAsiaAttentionAustraliaAwardBar CodesBeckwith-Wiedemann SyndromeBeta CellBindingBinding SitesBiological AssayBooksBrain InjuriesBrothersCDKN1C geneCalciumCalcium SignalingCandidate Disease GeneCatalogingCatalogsCell membraneCell physiologyChildChildhoodChromosomes, Human, Pair 11ClinicalClinical ResearchCodeCollaborationsComplementary DNAComputer SimulationCongenital AbnormalityCongestiveDNADNA SequenceDNA replicaseDataData AnalysesDefectDevelopmentDiabetes MellitusDiagnosisDiazoxideDideoxy Chain Termination DNA SequencingDiffuseDiseaseDistalDominant GenesDominant-Negative MutationDuct (organ) structureDumping SyndromeElectrophoretic Mobility Shift AssayEndocrineEndocrinologyEnglandEpigallocatechin GallateEpigenetic ProcessEtiologyEuropeEuropeanExcisionExerciseFailureFamilyFamily history ofFamily memberFanconi SyndromeFastingFathersFibroblastsFreezingFrequenciesFructokinasesFunctional RNAFutureGLUT2 geneGene MutationGenerationsGenesGeneticGenomeGenomic DNAGenotypeGlucagonGlucokinaseGlucoseGlucose Plasma ConcentrationGlycogenGlycolysisGoalsGrantGuidelinesHaplotypesHead of pancreasHistologicHistologyHormonesHumanHyperammonemiaHyperinsulinismHypertrophic CardiomyopathyHypertrophyHypoglycemiaIRS1 geneIn VitroIncidenceIndividualInfantInheritedInstructionInsulinInternationalIntestinesIntussusceptionInvestigationIonsIslet CellIslets of LangerhansItalyJointsJournalsKidneyLabelLesionLifeLinkLiteratureLithium ChlorideLiverLiver DysfunctionLongitudinal StudiesLoss of HeterozygosityLymphocyteManuscriptsMeasuresMediator of activation proteinMedicalMedicineMethodsMethylationMicroRNAsMicroarray AnalysisMissense MutationMitochondrial DNAModelingMolecularMolecular AnalysisMolecular GeneticsMono-SMonographMorbidity - disease rateMosaicismMutationMutation AnalysisMutation DetectionNatureNecrotizing EnterocolitisNegative StainingNeurologicNew EnglandNewborn InfantNormal tissue morphologyNorth AmericaNuclearOctreotideOncogenesOperative Surgical ProceduresOralOrganOther GeneticsPIK3CA genePancreasPancreatectomyPaperParis, FrancePathogenesisPathologyPathway interactionsPatientsPatternPediatric HospitalsPediatricsPeripheral Blood Mononuclear CellPersistent Hyperinsulinemia Hypoglycemia of InfancyPharmaceutical PreparationsPharmacotherapyPhenotypePhiladelphiaPhosphoglucomutasePhysiologicalPlayPositron-Emission TomographyPreparationPrincipal InvestigatorProceduresProgress ReportsPromoter RegionsProtein BindingProteinsPublicationsPublishingReactionRecruitment ActivityRegulationReportingResearchResearch PersonnelResearch Project GrantsResectableResectedResistanceResolutionRett SyndromeRiskRoleRouteRoux-en-Y AnastomosisSamplingScanningSeizuresSeriesSisterSiteSocietiesSouth AmericaSpecificityStaining methodStainsSubgroupSyndromeTailTechniquesTestingTimeTimeLineTissuesTrans-ActivatorsTranscriptional RegulationTranslational ResearchTravelTumor Suppressor ProteinsTurner&aposs SyndromeUCP2 proteinValidationVariantWorkWritingX ChromosomeZincabstractingacyl-CoA dehydrogenasebasecleft lip and palateclinical phenotypedesigndisease-causing mutationeditorialepigenetic markerexomeexome sequencingexperiencegain of function mutationgamma hydroxybutyrategamma-Aminobutyric Acidgenetic associationgenetic linkage analysisgenetic pedigreegenome sequencingglucagon-like peptide 1glucose metabolismglycosylationhexokinasehigh riskimprintimprovedinduced pluripotent stem cellinfancyinfant of diabetic motherinhibitor/antagonistinsertion/deletion mutationinsightinsulin secretioninsulin signalinginsulinomainterestisletlecturesmeetingsmortalitymouse modelmutantneonatenew technologynext generation sequencingnoveloffspringparacrinepartial responseperipheral bloodpreclinical studypreventprogramspromoterreceptorresearch studyresponsescreeningshunt pathwaystandard of caresuccesssymposiumtraffickingtranscription factortranscription factor CP2transcriptome sequencingtransmission processtumortumor growth
项目摘要
Congenital hyperinsulinism (HI) is the most frequent cause of persistent hypoglycemia in infants and
children. Children with HI are at high risk of seizures and permanent brain damage and treatment of their
hypoglycemia is extremely difficult. Recent work has shown that HI is associated with genetic defects in the
pathways regulating beta-cell insulin secretion. Although 9 such loci have been found, many children with HI
have no identifiable mutation of these genes. This includes one-third of diffuse HI cases that require
pancreatectomy and half of cases that are responsive to medical treatment with diazoxide. Our hypothesis is
that hyperinsulinism in these groups of children involves both novel molecular defects of known loci, as well
as, previously unrecognized new genetic loci. The long-term goals of the research are to identify genotype-
phenotype correlations in these disorders to guide diagnosis and treatment and to uncover new forms of
congenital hyperinsulinism. A i m i will extend and expand studies of the novel genetic locus for
hyperinsulinism in the historically-important dominant HI family reported by McQuarrie in 1954. Clinical
phenotyping, linkage analysis, and next-gen sequencing methods have identified HK1 as a likely candidate
gene. This will be confirmed by recruitment of additional pedigrees and by functional assays. Aim 2 will
extend the search for defects in novel candidate genes in our large series of children with diazoxide
responsive hyperinsulinism that have no identifiable mutation. We will seek to identify either post-zygotic
mutations of known loci or novel additional loci using targeted next-gen sequencing methods. Aim 3 will
continue our efforts to define the mechanisms of molecular defects in children who fail to respond to
diazoxide and require pancreatectomy. We will search for novel cryptic or mosaic mutations of the two
adjacent genes on l i p that are responsible for most cases of this form of HI: ABCC8/SUR1 and
KCNJ11/Kir6.2. This will include functional testing of insulin release and molecular analysis of cultured islets
from patients undergoing surgery to identify post-zygotic, mosaic mutations; mutations in non-coding
regions, and microRNA sites; or epigenetic methylation defects.
RELEVANCE (See instructions):
This translational research project seeks to define the molecular causes of congenital hyperinsulinemic
hypoglycemia (HI). Novel candidate genes will be sought using next-gen DNA sequencing and advanced
micro-methods to study pancreatic islets from children requiring pancreatectomy. The results will improve the
treatment of children with HI and provide new insight into regulation of insulin secretion in normal humans.
先天性高胰岛素血症(HI)是婴幼儿持续低血糖的最常见原因
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLES ALFRED STANLEY其他文献
CHARLES ALFRED STANLEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLES ALFRED STANLEY', 18)}}的其他基金
Islet Dysregulation in Infants with Congenital Hyperinsulinism
先天性高胰岛素血症婴儿的胰岛失调
- 批准号:
9249526 - 财政年份:2014
- 资助金额:
$ 71.79万 - 项目类别:
Islet Dysregulation in Infants with Congenital Hyperinsulinism
先天性高胰岛素血症婴儿的胰岛失调
- 批准号:
8826730 - 财政年份:2014
- 资助金额:
$ 71.79万 - 项目类别:
Meso Scale Discovery Sector 6000 Imager
Meso Scale Discovery Sector 6000 成像仪
- 批准号:
7794431 - 财政年份:2010
- 资助金额:
$ 71.79万 - 项目类别:
Molecular Basis of a New Form of Hyperinsulinism
新型高胰岛素血症的分子基础
- 批准号:
7992519 - 财政年份:2010
- 资助金额:
$ 71.79万 - 项目类别:
International Medical Conference of Congenital Hyperinsulinism
先天性高胰岛素血症国际医学会议
- 批准号:
7162041 - 财政年份:2006
- 资助金额:
$ 71.79万 - 项目类别:
TREATMENT OPTIONS FOR TYPE 2 DIABETES IN ADOLESCENTS AND YOUTH
青少年 2 型糖尿病的治疗方案
- 批准号:
7207762 - 财政年份:2005
- 资助金额:
$ 71.79万 - 项目类别:
ISLET DYSREGULATION IN INFANTS WITH CONGENITAL HYPERINSULINISM
先天性高胰岛素血症婴儿的胰岛失调
- 批准号:
7207678 - 财政年份:2005
- 资助金额:
$ 71.79万 - 项目类别:
Islet dysregulation in infants with congenital hyperinsulinism
先天性高胰岛素血症婴儿的胰岛失调
- 批准号:
7041801 - 财政年份:2004
- 资助金额:
$ 71.79万 - 项目类别:
Ped Endocrine Fellowship Training in Diabetes Research
Ped 糖尿病研究内分泌奖学金培训
- 批准号:
6930328 - 财政年份:2002
- 资助金额:
$ 71.79万 - 项目类别:
Pediatric Endocrine Fellowship Training in Diabetes Research
糖尿病研究中的儿科内分泌奖学金培训
- 批准号:
7883438 - 财政年份:2002
- 资助金额:
$ 71.79万 - 项目类别:
相似海外基金
Natural History and Genetic Studies of Usher Syndrome
亚瑟综合症的自然史和遗传学研究
- 批准号:
8556889 - 财政年份:
- 资助金额:
$ 71.79万 - 项目类别:
Identifying New Glioma-Associated Tumor Suppressors and Oncogenes
鉴定新的神经胶质瘤相关肿瘤抑制因子和癌基因
- 批准号:
10014745 - 财政年份:
- 资助金额:
$ 71.79万 - 项目类别:
Natural History and Genetic Studies of Usher Syndrome
亚瑟综合症的自然史和遗传学研究
- 批准号:
10266900 - 财政年份:
- 资助金额:
$ 71.79万 - 项目类别:
Natural History and Genetic Studies of Usher Syndrome
亚瑟综合症的自然史和遗传学研究
- 批准号:
10930523 - 财政年份:
- 资助金额:
$ 71.79万 - 项目类别:
Natural History and Genetic Studies of Usher Syndrome
亚瑟综合症的自然史和遗传学研究
- 批准号:
9362412 - 财政年份:
- 资助金额:
$ 71.79万 - 项目类别:
Identifying New Glioma-Associated Tumor Suppressors and Oncogenes
鉴定新的神经胶质瘤相关肿瘤抑制因子和癌基因
- 批准号:
10486899 - 财政年份:
- 资助金额:
$ 71.79万 - 项目类别:
Identifying New Glioma-Associated Tumor Suppressors and Oncogenes
鉴定新的神经胶质瘤相关肿瘤抑制因子和癌基因
- 批准号:
8349326 - 财政年份:
- 资助金额:
$ 71.79万 - 项目类别:
Identifying New Glioma-Associated Tumor Suppressors and Oncogenes
鉴定新的神经胶质瘤相关肿瘤抑制因子和癌基因
- 批准号:
10262381 - 财政年份:
- 资助金额:
$ 71.79万 - 项目类别:
Natural History and Genetic Studies of Usher Syndrome
亚瑟综合症的自然史和遗传学研究
- 批准号:
8737686 - 财政年份:
- 资助金额:
$ 71.79万 - 项目类别:
Identifying New Glioma-Associated Tumor Suppressors and Oncogenes
鉴定新的神经胶质瘤相关肿瘤抑制因子和癌基因
- 批准号:
10926255 - 财政年份:
- 资助金额:
$ 71.79万 - 项目类别:














{{item.name}}会员




